Easywell Biomedicals Statistics

Total Valuation

Easywell Biomedicals has a market cap or net worth of TWD 8.29 billion. The enterprise value is 8.27 billion.

Market Cap	8.29B
Enterprise Value	8.27B

Important Dates

The last earnings date was Tuesday, November 12, 2024.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Easywell Biomedicals has 121.87 million shares outstanding. The number of shares has increased by 2.15% in one year.

Current Share Class	n/a
Shares Outstanding	121.87M
Shares Change (YoY)	+2.15%
Shares Change (QoQ)	+3.31%
Owned by Insiders (%)	9.09%
Owned by Institutions (%)	0.03%
Float	54.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.98
PB Ratio	11.19
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-58.46
EV / Sales	22.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-37.51

Financial Position

The company has a current ratio of 4.02, with a Debt / Equity ratio of 0.55.

Current Ratio	4.02
Quick Ratio	2.89
Debt / Equity	0.55
Debt / EBITDA	n/a
Debt / FCF	-1.86
Interest Coverage	-7.85

Financial Efficiency

Return on equity (ROE) is -23.29% and return on invested capital (ROIC) is -8.84%.

Return on Equity (ROE)	-23.29%
Return on Assets (ROA)	-7.79%
Return on Capital (ROIC)	-8.84%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.28
Inventory Turnover	1.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +71.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+71.27%
50-Day Moving Average	117.38
200-Day Moving Average	109.18
Relative Strength Index (RSI)	25.47
Average Volume (20 Days)	675,114

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Easywell Biomedicals had revenue of TWD 361.49 million and -141.46 million in losses. Loss per share was -1.21.

Revenue	361.49M
Gross Profit	230.14M
Operating Income	-158.59M
Pretax Income	-166.96M
Net Income	-141.46M
EBITDA	-114.08M
EBIT	-158.59M
Loss Per Share	-1.21

Full Income Statement

Balance Sheet

The company has 433.19 million in cash and 410.43 million in debt, giving a net cash position of 22.76 million or 0.19 per share.

Cash & Cash Equivalents	433.19M
Total Debt	410.43M
Net Cash	22.76M
Net Cash Per Share	0.19
Equity (Book Value)	745.19M
Book Value Per Share	6.07
Working Capital	508.35M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -203.04 million and capital expenditures -17.39 million, giving a free cash flow of -220.43 million.

Operating Cash Flow	-203.04M
Capital Expenditures	-17.39M
Free Cash Flow	-220.43M
FCF Per Share	-1.81

Full Cash Flow Statement

Margins

Gross margin is 63.66%, with operating and profit margins of -43.87% and -39.13%.

Gross Margin	63.66%
Operating Margin	-43.87%
Pretax Margin	-46.19%
Profit Margin	-39.13%
EBITDA Margin	-31.56%
EBIT Margin	-43.87%
FCF Margin	-60.98%

Dividends & Yields

Easywell Biomedicals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.15%
Shareholder Yield	-2.15%
Earnings Yield	-1.78%
FCF Yield	-2.66%

Stock Splits

The last stock split was on September 30, 2022. It was a reverse split with a ratio of 0.7.

Last Split Date	Sep 30, 2022
Split Type	Reverse
Split Ratio	0.7

Scores

Easywell Biomedicals has an Altman Z-Score of 4.9.

Altman Z-Score	4.9
Piotroski F-Score	n/a